National Human Genome Research Institute; Notice of Closed Meetings, 5250 [2024-01523]

Download as PDF 5250 Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices Date: March 13, 2024. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892. Contact Person: Preethy Nayar, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, 301–443–4577, nayarp2@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: January 22, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–01568 Filed 1–25–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meetings lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Center for ELSI Resource and Analysis (CERA). Date: March 13, 2024. Time: 2:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 20892, (301) 402–8739, pozzattr@ mail.nih.gov. VerDate Sep<11>2014 18:02 Jan 25, 2024 Jkt 262001 Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Data Integration and Statistical Analysis Methods (DISAM). Date: March 15, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute for Human Genome Research, National Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 20892, (301) 402–8823, wheelansj@nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Advancing Genomic Medicine Research (AGMR). Date: March 18, 2024. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute for Human Genome Research, National Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 20892, (301) 402–8823, wheelansj@nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Genomics & Health Equity. Date: March 22, 2024. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 20892, (301) 402–0838, pozzattr@ mail.nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Diversity Action Plan (DAP). Date: March 26, 2024. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute for Human Genome Research, National Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 20892, (301) 402–8823, wheelansj@nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Genomic and Data Science Education. Date: March 28, 2024. Time: 11:00 a.m. to 3:00 p.m. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. Contact Person: Keith McKenney, Ph.D., Scientific Review Officer, National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 20892, (301) 717– 2348, mckenneyk@mail.nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Network of Genomics Enabled Learning Health Systems. Date: March 29, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute for Human Genome Research, National Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 20892, (301) 402–8823, wheelansj@nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Pangenome Informatics Tools. Date: April 5, 2024. Time: 12:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. Contact Person: Keith McKenney, Ph.D., Scientific Review Officer, National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 20892, (301) 717– 2348, mckenneyk@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: January 22, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–01523 Filed 1–25–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., E:\FR\FM\26JAN1.SGM 26JAN1

Agencies

[Federal Register Volume 89, Number 18 (Friday, January 26, 2024)]
[Notices]
[Page 5250]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01523]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel; Center for ELSI Resource and Analysis 
(CERA).
    Date: March 13, 2024.
    Time: 2:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Human Genome Research 
Institute, National Institutes of Health, 6700B Rockledge Drive, MSC 
6908, Bethesda, MD 20892, (301) 402-8739, [email protected].

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel; Data Integration and Statistical Analysis 
Methods (DISAM).
    Date: March 15, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Institute for Human 
Genome Research, National Institutes of Health, 6700B Rockledge 
Drive, MSC 6908, Bethesda, MD 20892, (301) 402-8823, 
[email protected].

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel; Advancing Genomic Medicine Research (AGMR).
    Date: March 18, 2024.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Institute for Human 
Genome Research, National Institutes of Health, 6700B Rockledge 
Drive, MSC 6908, Bethesda, MD 20892, (301) 402-8823, 
[email protected].

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel; Genomics & Health Equity.
    Date: March 22, 2024.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Human Genome Research 
Institute, National Institutes of Health, 6700B Rockledge Drive, MSC 
6908, Bethesda, MD 20892, (301) 402-0838, [email protected].

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel; Diversity Action Plan (DAP).
    Date: March 26, 2024.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Institute for Human 
Genome Research, National Institutes of Health, 6700B Rockledge 
Drive, MSC 6908, Bethesda, MD 20892, (301) 402-8823, 
[email protected].

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel; Genomic and Data Science Education.
    Date: March 28, 2024.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Keith McKenney, Ph.D., Scientific Review 
Officer, National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 
20892, (301) 717-2348, [email protected].

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel; Network of Genomics Enabled Learning Health 
Systems.
    Date: March 29, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Institute for Human 
Genome Research, National Institutes of Health, 6700B Rockledge 
Drive, MSC 6908, Bethesda, MD 20892, (301) 402-8823, 
[email protected].

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel; Pangenome Informatics Tools.
    Date: April 5, 2024.
    Time: 12:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Keith McKenney, Ph.D., Scientific Review 
Officer, National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, MSC 6908, Bethesda, MD 
20892, (301) 717-2348, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: January 22, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01523 Filed 1-25-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.